Sialoglycoconjugates in primary and recurrent mixed tumors of lacrimal glands

Koichi Hayakawa, Makoto Ishikawa, Tohru Abe, Ryuko Nakayama, Kunihiko Yamaki, Shozo Sakuragi

研究成果: Article査読

1 被引用数 (Scopus)

抄録

We examined the activity of Griffonia simplicifolia II agglutinin (GS2) before and after neuraminidase treatment in 2 cases of primary benign mixed tumor (BMT) and a case of recurrent mixed tumor (MT). Histologically, each type of MT is comprised of epithelial and mesenchymal components. GS2, which showed no binding to either structural component in the primary BMT, was specifically bound to the mesenchymal component in the recurrent MT. After neuraminidase treatment, there was a marked increase in GM-binding levels in the epithelial component of the primary BMT and in both components of the recurrent MT. These results might reveal a prominent sialylation in the recurrent MT.

本文言語English
ページ(範囲)374-379
ページ数6
ジャーナルOphthalmic Research
30
6
DOI
出版ステータスPublished - 1998 11月
外部発表はい

ASJC Scopus subject areas

  • 眼科学
  • 感覚系
  • 細胞および分子神経科学

フィンガープリント

「Sialoglycoconjugates in primary and recurrent mixed tumors of lacrimal glands」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル